CVS Health Corp
CVS
Market Cap$84.87B
Close$
Earnings Call Q4 2023
February 7, 2024 - AI Summary
CVS Health reported strong financial results for the fourth quarter of 2023, with revenues increasing by nearly 12% and adjusted EPS of $2.12.
The company revised its full-year 2024 guidance for adjusted EPS to at least $8.30 and cash flow from operations to at least $12 billion due to cautiousness around Medicare Advantage utilization trends.
Utilization pressure in Medicare Advantage continues to be a challenge, impacting the medical benefit ratio (MBR) and overall profitability of the business segment.
Exclusive for Stockcircle Pro members
Sign up
$81.74
21.7% upside
Current Fair Value
21.7% upsideUndervalued by 21.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.87 Billion |
|---|---|
| Enterprise Value | $135.02 Billion |
| Dividend Yield | $2.5062 (3.72%) |
| Earnings per Share | $6.47 |
| Beta | 0.0 |
| Outstanding Shares | 1,260,480,127 |
| Avg 30 Day Volume | 8,825,883 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 10.17 |
|---|---|
| PEG | -91.46 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 1.12 |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | 9.25 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
ESG Score
No data
About CVS Health Corp
CEO: Larry Merlo